Finland vs Netherlands: Share of E. coli infections resistant to cephalosporins
Finland
6.7%
in 2022
Netherlands
7.6%
in 2022
Finland rank
45th
Netherlands rank
43rd
Share of E. coli infections resistant to cephalosporins over time
- Finland
- Netherlands
How they compare
Netherlands currently reports 7.6% against 6.7% in Finland, a difference of 0.9%.
That makes Netherlands's figure about 1.1 times Finland's.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was Netherlands ahead.
Finland ranks 45th and Netherlands ranks 43rd of 46 countries.
Across the 2 decades both report, Finland averaged higher in 1 and Netherlands in 1.
Head to head by decade
| Decade | Finland | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 7.2% | 6.9% | 0.3% | Finland |
| 2020s | 6.5% | 7.0% | 0.4% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Finland or Netherlands?
- Netherlands, at 7.6% against 6.7% in Finland as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Finland and Netherlands?
- 0.9%, with Netherlands ahead.
- How many years of comparable data are there for Finland and Netherlands?
- 6 years are reported by both, from 2017 to 2022.
- How do Finland and Netherlands rank globally for share of e. coli infections resistant to cephalosporins?
- Finland ranks 45th and Netherlands ranks 43rd of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).